Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-606-2284
Fax+1 206-606-6414
Dr. Hawley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mailman School of Public Health at Columbia UniversityMS, Biostatistics (Patient-Oriented Reaearch), 2020 - 2022
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2017 - 2020
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
- University of Wisconsin School of Medicine & Public HealthClass of 2011
Certifications & Licensure
- CA State Medical License 2015 - Present
- WA State Medical License 2021 - 2026
- NY State Medical License 2017 - 2022
- MA State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody® against PSMA, CD137, and albumin in patients with PSMA-positive solid tumors.Johann S de Bono, Anja Williams, Ignacio Melero, Anuradha Jayaram, Jessica E Hawley
Clinical Cancer Research. 2025-03-17 - Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.Lisa N Chesner, Fanny Polesso, Julie N Graff, Jessica E Hawley, Alexis K Smith
Cancer Discovery. 2025-03-03 - Association of Prior PARP Inhibitor Exposure with Clinical Outcomes afterLu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous R...Ruben Raychaudhuri, Abuzar Moradi Tuchayi, Soon Khai Low, Ali T Arafa, Laura S Graham
European Urology Oncology. 2025-02-06
Press Mentions
- Assessing Regional Differences in COVID-19 Outcomes Among Patients with CancerJanuary 4th, 2022
- The Prostate Cancer Foundation Announces 2020 Young Investigator Awards Totaling $6 Million for Prostate Cancer ResearchDecember 16th, 2020
- A COVID-19-Cancer InterplayOctober 7th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: